| 000 | 01722 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514191816.0 | ||
| 264 | 0 | _c20040817 | |
| 008 | 200408s 0 0 eng d | ||
| 022 | _a1568-0266 | ||
| 024 | 7 |
_a10.2174/1568026043388330 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRandolph, John T | |
| 245 | 0 | 0 |
_aPeptidomimetic inhibitors of HIV protease. _h[electronic resource] |
| 260 |
_bCurrent topics in medicinal chemistry _c2004 |
||
| 300 |
_a1079-95 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnti-HIV Agents _xchemistry |
| 650 | 0 | 4 | _aAtazanavir Sulfate |
| 650 | 0 | 4 | _aCarbamates |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDipeptides _xchemistry |
| 650 | 0 | 4 | _aFurans |
| 650 | 0 | 4 |
_aHIV _xdrug effects |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndinavir _xpharmacology |
| 650 | 0 | 4 | _aLopinavir |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Mimicry |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aNelfinavir _xpharmacology |
| 650 | 0 | 4 |
_aOligopeptides _xchemistry |
| 650 | 0 | 4 |
_aOrganophosphates _xchemistry |
| 650 | 0 | 4 |
_aPeptides _xchemistry |
| 650 | 0 | 4 |
_aPhenylbutyrates _xchemistry |
| 650 | 0 | 4 |
_aPyridines _xchemistry |
| 650 | 0 | 4 |
_aPyrimidinones _xchemistry |
| 650 | 0 | 4 |
_aRitonavir _xchemistry |
| 650 | 0 | 4 |
_aSaquinavir _xchemistry |
| 650 | 0 | 4 |
_aSulfonamides _xchemistry |
| 650 | 0 | 4 |
_aUrethane _xanalogs & derivatives |
| 700 | 1 | _aDeGoey, David A | |
| 773 | 0 |
_tCurrent topics in medicinal chemistry _gvol. 4 _gno. 10 _gp. 1079-95 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1568026043388330 _zAvailable from publisher's website |
| 999 |
_c14899636 _d14899636 |
||